Molecular basis of subtotal complement C6 deficiency. A carboxy-terminally truncated but functionally active C6

J Clin Invest. 1995 Apr;95(4):1877-83. doi: 10.1172/JCI117868.

Abstract

Individuals with subtotal complement C6 deficiency possess a C6 molecule that is 14% shorter than normal C6 and present in low but detectable concentrations (1-2% of the normal mean). We now show that this dysmorphic C6 is bactericidally active and lacks an epitope that was mapped to the most carboxy-terminal part of C6 using C6 cDNA fragments expressed as fusion proteins in the pUEX expression system. We thus predicted that the abnormal C6 molecule might be carboxy-terminally truncated and sought a mutation in an area approximately 14% from the carboxy-terminal end of the coding sequence. By sequencing PCR-amplified products from this region, we found, in three individuals from two families, a mutation that might plausibly be responsible for the defect. All three have an abnormal 5' splice donor site of intron 15, which would probably prevent splicing. An in-frame stop codon is found 17 codons downstream from the intron boundary, which would lead to a truncated polypeptide 13.5% smaller than normal C6. This result was unexpected, as earlier studies mapped the C5b binding site, or a putative enzymatic region, to this part of C6. Interestingly, all three subjects were probably heterozygous for both subtotal C6 and complete C6 deficiency.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Base Sequence
  • Blood Bactericidal Activity
  • Child
  • Complement C6 / deficiency*
  • Complement C6 / genetics*
  • Complement C6 / immunology
  • Complement Membrane Attack Complex
  • Epitopes
  • Humans
  • Immune System Diseases / genetics*
  • Immunoblotting
  • Male
  • Meningococcal Infections / immunology
  • Molecular Sequence Data
  • Polymerase Chain Reaction
  • RNA Splicing
  • Sequence Analysis, DNA

Substances

  • Complement C6
  • Complement Membrane Attack Complex
  • Epitopes